Sharon Kochan, Executive VP U.S. Generics at PERRIGO CO (PRGO), sold 5,216 shares at $96.63 ($502K) on 2011-08-30, disclosed to the SEC on 2011-09-01.
Open-market sale of $502k PRGO by Executive VP U.S. Generics. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $95.71 | 2,303 | $220K | 43.9% |
| 2 | $96.63 | 2,913 | $281K | 56.1% |
| Total | $96.22 avg | 5,216 | $502K | 100% |
| Filing → |
| PRGO | SELL | 2016-03-04 | $373K | — | Filing → |
| PRGO | SELL | 2014-11-12 | $839K | — | Filing → |
| PRGO | SELL | 2013-11-19 | $69K | — | Filing → |